CClinicalTrials.gg
CompletedNCT06041542Updated Sep 18, 2023

Evaluation of the Screening Effect of Artificial Intelligence Hand Activity Evaluation System for Cervical Spondylosis

An observational study in 10-second G&R Test, sponsored by Guangdong Provincial People's Hospital. Completed at 1 site in China. Open to participants aged 40 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-18.

Sponsored by Guangdong Provincial People's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1,380
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study:

  1. Build an artificial intelligence screening tool for cervical spondylosis based on hand function analysis;
  2. Verify the accuracy of cervical spondylosis screening tools.
Read the detailed description

Cervical spondylotic myelopathy (CSM) has a high incidence in the middle-aged and elderly people. According to clinical research, the surgeon can makes a preliminary assessment of the severity of CSM based on a 10-second grip and release (G\&R) test. The statistics of G\&R test mainly rely on the surgeon's manual counting. When a patient's hand motion speed is too fast, the surgeon's manual counting is prone to error, leading to potential misdiagnosis. We construct and verify the intelligent video analysis system for Grip-\&-release. The system has a high accuracy and inference speed that ensure the proposed model can be used as a screening examination tool for CSM and a medical assistance tool to help decision making during CSM treatment planning.

02

Conditions studied

  • 10-second G&R Test

Browse trials for

Keywords

  • 10-second G&R test
  • cervical spondylotic myelopathy
  • hand motion analysis
  • video analysis
03

In context

Spondylosis

144 studies on the registry are indexed under Spondylosis; 41 are open to participants now.

This study's enrollment of 1,380 is above the median of 100 across 40 observational studies indexed under Spondylosis.

Browse Spondylosis studies →

Lead sponsor

Guangdong Provincial People's Hospital is the lead sponsor of 231 studies on the registry; 101 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

1000 asymptomatic population in community; 200 cases of cervical spondylosis; Arthritis, Parkinson's disease, cerebral apoplexy 60 patients each.

Inclusion criteria

  1. Age between 18-80 years old;
  2. Patients who have received cervical CT or MR examination within the last month and have been clearly diagnosed or excluded from cervical spondylosis (i.e., those who have been clearly diagnosed before participating in the study);
  3. People who are willing to participate in the study with CT/MR examination (i.e., those who have not been diagnosed before joining the study).

Exclusion criteria

Exclusion Criteria:

  1. Subjects with cervical spondylosis who have been examined but still cannot be definitively diagnosed or ruled out;
  2. Subjects with definite presence of hand trauma;
  3. People who do not have access to CT or MR;
  4. Subjects who did not comply with the examination, were unable to perform neurological assessment, or were unable to fill out questionnaires.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1,380 participants (actual)
Patient registry
No

Groups and cohorts

  • Case group

    Collect video of hand grasping from patients with cervical spondylotic myelopathy through intelligent video analysis system.

    Diagnostic Test: 10-second hand grip and release test

  • Control group

    Collect video of hand grasping from normal people through intelligent video analysis system.

    Diagnostic Test: 10-second hand grip and release test

  • Differentiate group

    Collect video of hand grasping from Stroke and Parkinson's disease through intelligent video analysis system.

    Diagnostic Test: 10-second hand grip and release test

Interventions

  • Diagnostic test10-second hand grip and release test

    To grip and release hand in ten seconds

06

What researchers measure

Primary outcomes

  1. mJOA score

    Correlate 10-second hand grip and release test with mJOA score

    Time frame: 2022-10-01-2022-12-30

07

Study locations

1 site
  • Guangdong Provincial People's Hospital
    Guangzhou, Guangdong 510080, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06041542
Lead sponsor
Guangdong Provincial People's Hospital
Responsible party
YunBing Chang (Head of spine Department, Guangdong Provincial People's Hospital) — Principal investigator
First posted
Sep 18, 2023
Start date
Dec 1, 2020
Primary completion
May 31, 2022
Completion
Dec 30, 2022
Last update
Sep 18, 2023

Study contacts

Yunbing Chang, M.D.
study chair · Guangdong Provincial People's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion